Tissue microarrays for gene amplification surveys in many different tumor types

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 1966-1975

  Schraml, Peter ^a   Kononen, Juha ^b   Bubendorf, Lukas ^b   Moch, Holger ^a   Bissig, Heidi ^a   Nocito, Antonio ^a   Mihatsch, Michael J ^a   Kallioniemi, Olli P ^b   Sauter, Guido ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL;

CYCLIN D1; GENE AMPLIFICATION; GENES, ERBB-2; GENETIC SCREENING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 0032787281     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Knuutila, S., Bjorkqvist, A. M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O., Szymanska, J., Larramendy, M. L., Tapper, J., Pere, H., El-Rifai, W., Hemmer, S., Wasenius, V. M., Vidgren, V., and Zhu, Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol., 152: 1107-1123, 1998.
2. Kononen, J., Bubendorf, L., Kallioniemi, A., Barlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., and Kallioniemi, O. P. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med., 4: 844-847, 1998.
3. Kallioniemi, O-P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., and Gray, J. W. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
4. Battifora, H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab. Invest., 55: 244-248, 1986.
5. Bonilla, M., Ramirez, M., Lopez-Cueto, J., and Gariglio, P. In vivo amplification and rearrangement of c-myc oncogene in human breast tumors. J. Natl. Cancer Inst., 80: 665-671, 1988.
6. Johnson, B. E., Makuch, R. W., Simmons, A. D., Gazdar, A. F., Burch, D., and Cashell, A. W. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res., 48: 5163-5166, 1988.
7. Koda, T., Matsushima, S., Sasaki, A., Danjo, Y., and Kakinuma, M. c-myc gene amplification in primary stomach cancer. Jpn. J. Cancer Res., 76: 551-554, 1985.
8. Nakasato, F., Sakamoto, H., Mori, M., Hayashi, K., Shimosato, Y., Nishi, M., Takao, S., Nakatani, K., Terada, M., and Sugimura, T. Amplification of the c-myc oncogene in human stomach cancers. Gunn, 75: 737-742, 1984.
9. Pluzhnikova, G. F., Serova, O. M., Kniazev, P. G., Fedorov, S. N., and Novikov, L. B. Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells. Eksp. Onkol., 9: 15-17, 1987.
10. Saksela, K., Bergh, J., Lehto, V. P., Nilsson, K., and Alitalo, K. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Cancer Res., 45: 1823-1827, 1985.
11. Shibuya, M., Yokota, J., and Ueyama, Y. Amplification and expression of a cellular oncogene (c-myc) in human gastric adenocarcinoma cells. Mol. Cell. Biol., 5: 414-418, 1985.
12. Wong, A. J., Ruppert, J. M., Eggleston, J., Hamilton, S. R., Baylin, S. B., and Vogelstein, B. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science (Washington DC), 233: 461-464, 1986.
13. Courjal, F., Louason, G., Speiser, P., Katsaros, D., Zeillinger, R., and Theillet, C. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors. Int. J. Cancer, 69: 247-253, 1996.
14. Esteller, M., Garcia, A., Martinez-Palones, J. M., Xercavins, J., and Reventos, J. Detection of clonality and genetic alterations in endometrial pipelle biopsy and its surgical specimen counterpart. Lab. Invest., 76: 109-116, 1997.
15. Czerwenka, K., Lu, Y., and Heuss, F. Amplification and expression of the c-erbB-2 oncogene in normal, hyperplastic, and malignant endometria. Int. J. Gynecol. Pathol., 14: 98-106, 1995.
16. Fournier, G., Latil, A., Amet, Y., Abalain, J. H., Volant, A., Mangin, P., Floch, H. H., and Lidereau, R. Gene amplifications in advanced-stage human prostate cancer. Urol. Res., 22: 343-347, 1995.
17. Bubendorf, L., Kononen, J., Koivisto, P., Schraml, P., Moch, H., Gasser, T. C., Willi, N., Mihatsch, M. J., Sauter, G., and Kallioniemi, O-P. Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res., 59: 803-806, 1999.
18. Latil, A., Baron, J. C., Cussenot, O., Fournier, G., Boccon-Gibod, L., Le Duc, A., and Lidereau, R. Oncogene amplifications in early-stage human prostate carcinomas. Int. J. Cancer, 59: 637-638, 1994.
19. Ross, J. S., Sheehan, C., Hayner-Buchan, A. M., Ambros, R. A., Kallakury, B. V., Kaufman, R., Fisher, H. A., and Muraca, P. J. HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization. Hum. Pathol., 28: 827-833, 1997.
20. Bringuier, P. P., Tamimi, Y., Schuuring, E., and Schalken, J. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene, 12: 1747-1753, 1996.
21. Sauter, G., Moch, H., Gudat, F., Mihatsch, M. J., Haley, J., Meecker, T., and Waldman, F. Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH). Verh. Dtsch. Ges. Pathol., 77: 247-251, 1993.
22. Proctor, A. J., Coombs, L. M., Cairns, J. P., and Knowles, M. A. Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene, 6: 789-795, 1991.
23. Zukerberg, L. R., Yang, W. I., Gadd, M., Thor, A. D., Koerner, F. C., Schmidt, E. V., and Arnold, A. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol., 8: 560-567, 1995.
24. Barbareschi, M., Pelosio, P., Caffo, O., Buttitta, F., Pellegrini, S., Barbazza, R., Dalla Palma, P., Bevilacqua, G., and Marchetti, A. Cyclin D1 gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int. J. Cancer, 74: 171-174, 1997.
25. Leach, F. S., Elledge, S. J., Sherr, C. J., Willson, J. K., Markowitz, S., Kinzler, K. W., and Vogelstein, B. Amplification of cyclin genes in colorectal carcinomas. Cancer Res., 53: 1986-1989, 1993.
26. Sutter, T., Doi, S., Carnevale, K. A., Arber, N., and Weinstein, I. B. Expression of cyclins D1 and E in human colon adenocarcinomas. J. Med., 28: 285-309, 1997.
27. Simpson, J. F., Quan, D. E., O'Malley, F., Odom-Maryon, T., and Clarke, P. E. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. Am. J. Pathol., 151: 161-168, 1997.
28. Kyomoto, R., Kumazawa, H., Toda, Y., Sakaida, N., Okamura, A., Iwanaga, M., Shintaku, M., Yamashita, T., Hiai, H., and Fukumoto, M. Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinoma. Int. J. Cancer, 74: 576-581, 1997.
29. Davidson, B. J., Lydiatt, W. M., Abate, M. P., Schantz, S. P., and Chaganti, R. S. Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma. Head Neck, 18: 512-521, 1996.
30. Akervall, J. A., Michalides, R. J., Mineta, H., Balm. A., Borg, A., Dictor, M. R., Jin, Y., Loftus, B., Mertens, F., and Wennerberg, J. P. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer (Phila.), 79: 380-389, 1997.
31. Callender, T., el-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/cydin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
32. el-Naggar, A. K., Steck, K., and Batsakis, J. G. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma. Cytometry, 21: 47-51, 1995.
33. Nogueira, C. P., Dolan, R. W., Gooey, J., Byahatti, S., Vaughan, C. W., Fuleihan, N. S., Grillone, G., Baker, E., and Dornanowski, G. Inactivation of p53 and amplification of cyclin D1 correlate with clinical outcome in head and neck cancer. Laryngoscope, 108: 345-350, 1998.
34. Jares, P., Fernandez, P. L., Campo, E., Nadal, A., Bosch, F., Aiza, G., Nayach, I., Traserra, J., and Cardesa, A. PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas. Cancer Res., 54: 4813-4817, 1994.
35. Xu, L., Davidson, B. J., Murty, V. V., Li, R. G., Sacks, P. G., Garin-Chesa, P., Schantz, S. P., and Chaganti, R. S. TP53 gene mutations and CCND1 gene amplification in head and neck squamous cell carcinoma cell lines. Int. J. Cancer, 59: 383-387, 1994.
36. Muller, D., Millon, R., Lidereau, R., Engelmann, A., Bronner, G., Flesch, H., Eber, M., Methlin, G., and Abecassis, J. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. Eur. J. Cancer B Oral. Oncol., 30B: 113-120, 1994.
37. Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, H. J., Ryder, W. D., Cerny, T., and Thatcher, N. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br. J. Cancer, 73: 294-300, 1996.
38. Marchetti, A., Doglioni, C., Barbareschi, M., Buttitta, F., Pellegrini, S., Gaeta, P., La Rocca, R., Merlo, G., Chella, A., Angeletti, C. A., Dalla Palma, P., and Bevilacqua, G. Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int. J. Cancer. 75: 187-192, 1998.
39. Maelandsmo, G. M., Florenes, V. A., Hovig, E., Oyjord, T., Engebraaten, O., Holm, R., Borresen, A. L., and Fodstad, O. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. Br. J. Cancer, 73: 909-916, 1996.
40. Walker, G. J., Flores, J. F., Glendening, J. M., Lin, A. H., Markl, I. D., and Fountain, J. W. Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer, 22: 157-163, 1998.
41. Han, E. K., Lim, J. T., Arber, N., Rubin, M. A., Xing, W. Q., and Weinstein, I. B. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. Prostate, 35: 95-101, 1998.
42. Akama, Y., Yasui, W., Yokozaki, H., Kuniyasu, H., Kitahara, K., Ishikawa, T., and Tahara, E. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res., 86: 617-621, 1995.
43. Zou, M., Shi, Y., Farid, N. R., and al-Sedairy, S. T. Inverse association between cyclin D1 overexpression and retinoblastoma gene mutation in thyroid carcinomas. Endocrine, 8: 61-64, 1998.
44. Sauter, G., Carroll, P., Moch, H., Kallioniemi, A., Kerschmann, R., Narayan, P., Mihatsch, M. J., and Waldman, F. M. c-myc copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am. J. Pathol., 146: 1131-1139, 1995.
45. Ottestad, L., Andersen, T. I., Nesland, J. M., Skrede, M., Tveit, K. M., Nustad, K., and Borresen, A. L. Amplification of c-erbB-2, int-2 and c-myc genes in node-negative breast carcinomas. Relationship to prognosis. Acta Oncol., 32: 289-294, 1993.
46. Lizard-Nacol, S., Arnould, L., Riedinger, J. M., Arnal, M., Collin, F., and Guerrin, J. Amplification of c-myc and c-erbβ-2 (HER-2/neu) in breast cancer without axillary lymph node metastasis: correlation with other prognostic parameters. Bull. Cancer, 81: 780-784, 1994.
47. Contegiacomo, A., Pizzi, C., De Marchis, L., Alimandi, M., Delrio, P., Di Palma, E., Petrella, G., Ottini, L., French, D., Frati, L., et al. High cell kinetics is associated with amplification of the int-2, bcl- 1, myc and crbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers. Int. J. Cancer, 61: 1-6, 1995.
48. Watson, P. H., Safneck, J. R., Le, K., Dubik, D., and Shiu, R. P. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis. J. Natl. Cancer Inst., 85: 902-907, 1993.
49. Borg, A., Baldetorp, B., Ferno, M., Olsson, H., and Sigurdsson, H. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer, 51: 687-691, 1992.
50. Berns, E. M., Klijn, J. G., van Staveren, I. L., Portengen, H., Noordegraaf, E., and Foekens, J. A. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors. Eur. J. Cancer, 28: 697-700, 1992.
51. Chen, Y., Dong, J., Lu, Y., and McGee, J. O. Quantitative detection of amplification of proto-oncogenes in breast cancer. Chin. Med. J. (Engl. Ed.)., 108: 849-854, 1995.
52. Tavassoli, M., Quirke, P., Farzaneh, F., Lock, N. J., Mayne, L. V., and Kirkham, N. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma Br. J. Cancer, 60: 505-510, 1989.
53. Roux-Dosseto, M., Romain, S., Dussault, N., Desideri, C., Piana, L., Bonnier, P., Tubiana, N., and Martin, P. M. c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. Eur. J. Cancer, 28A: 1600-1604, 1992.
54. Rochlitz, C. F., Herrmann, R., and de Kant, E. Overexpression and amplification of c-myc during progression of human colorectal cancer. Oncology, 53: 448-454, 1996.
55. Wang, J., Li, L., Li, S., Cui, H., and Shen, G. A study of c-myc oncogene expression and amplification in colorectal cancer. Chin. Med. Sci. J., 9: 24-28, 1994.
56. Borst, M. P., Baker, V. V., Dixon, D., Hatch, K. D., Shingleton, H. M., and Miller, D. M. Oncogene alterations in endometrial carcinoma. Gynecol. Oncol., 38: 364-366, 1990.
57. Somers, K. D., Cartwright, S. L., and Schechter, G. L. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Oncogene, 5: 915-920, 1990.
58. Leonard, J. H., Kearsley, J. H., Chenevix-Trench, G., and Hayward, N. K. Analysis of gene amplification in head and neck squamous cell carcinoma. Int. J. Cancer, 48: 511-515, 1991.
59. Merritt, W. D., Weissler, M. C., Turk, B. F., and Gilmer, T. M. Oncogene amplification in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 116: 1394-1398, 1990.
60. Volling, P., Jungehulsing, M., Tesch, H., and Stennert, E. Oncogenes in squamous epithelial cancers in the area of the head and neck. Laryngol. Rhinol. Otol., 67: 160-164, 1988.
61. Haughey, B. H., von Hoff, D. D., Windle, B. E., Wahl, G. M., and Mock, P. M. c-myc oncogene copy number in squamous carcinoma of the head and neck. Am. J. Otolaryngol., 13: 168-171, 1992.
62. Kozma, L., Kiss, I., Szakall, S., and Ember, I. Investigation of c-myc oncogene amplification in colorectal cancer. Cancer Lett., 81: 165-169, 1994.
63. Sekine, I., Takami, S., Guang, S. G., Yokose, T., Kodama, T., Nishiwaki, Y., Kinoshita, M., Matsumoto, H., Ogura, T., and Nagai, K. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer. Oncol. Rep., 5: 351-354, 1998.
64. Noguchi, M., Hirohashi, S., Hara, F., Kojima, A., Shimosato, Y., Shinkai, T., and Tsuchiya, R. Heterogenous amplification of myc family oncogenes in small cell lung carcinoma. Cancer (Phila.), 66: 2053-2058, 1990.
65. Berns, E. M., Klijn, J. G., Henzen-Logmans, S. C., Rodenburg, C. J., van der Burg, M. E., and Foekens, J. A. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int. J. Cancer, 52: 218-224, 1992.
66. Sasano, H., Garrett, C. T., Wilkinson, D. S., Silverberg, S., Comerford, J., and Hyde, J. Protooncogene amplification and tumor ploidy in human ovarian neoplasms. Hum. Pathol., 21: 382-391, 1990.
67. Liu, J., Voutilainen, R., Kahri, A. I., and Heikkila, P. Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas. J. Endocrinol., 152: 175-181, 1997.
68. Jenkins, R. B., Qian, J., Lieber, M. M., and Bostwick, D. G. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res., 57: 524-531, 1997.
69. Ranzani, G. N., Pellegata, N. S., Previdere, C., Saragoni, A., Vio, A., Maltoni, M., and Amadori, D. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. Cancer Res., 50: 7811-7814, 1990.
70. Nakata, B., Onoda, N., Chung, Y. S., Maeda, K., Nishimura, S., Yashiro, M., Nitta, A., Kubo, T., Kato, Y., and Sowa, M. Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein. Gan. To. Kagaku Ryoho., 22: 176-179, 1995.
71. Hajdu, J., Kozma, L., Kiss, I., Szentkereszty, Z., Szakall, S., and Ember, I. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer? Acta Chir. Hung., 36: 119-121, 1997.
72. Schmidt, B., Ackermann, R., Hartmann, M., and Strohmeyer, T. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors. J. Urol., 158: 2000-2005, 1997.
73. Terrier, P., Sheng, Z. M., Schlumberger, M., Tubiana, M., Caillou, B., Travagli, J. P., Fragu, P., Parmentier, C., and Riou, G. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. Br. J. Cancer, 57: 43-47, 1988.
74. Yang, Y. Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma. Chung-Hua. I Hsueh Tsa Chih, 71: 304-306, 1991.
75. Mellon, J. K., Lunec, J., Wright, C., Horne, C. H., Kelly, P., and Neal, D. E. c-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value. J. Urol., 155: 321-326, 1996.
76. Sauter, G., Moch, H., Moore, D., Carroll, P., Kerschmann, R., Chew, K., Mihatsch, M. J., Gudat, F., and Waldman, F. Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res., 53: 2199-2203, 1993.
77. Gorgoulis, V. G., Barbatis, C., Poulias, I., and Karameris, A. M. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients. Mod. Pathol., 8: 758-764, 1995.
78. Orlando, C., Sestini, R., Vona, G., Pinzani, P., Bianchi, S., Giacca, M., Pazzagli, M., and Selli, C. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique. J. Urol., 156: 2089-2093, 1996.
79. Prost, S., Le, M. G., Douc-Rasy, S., Ahomadegbe, J. C., Spielmann, M., Guerin, M., and Riou, G. Association of c-erbB2-gene amplification with poor prognosis in non-inflammatory breast carcinomas but not in carcinomas of the inflammatory type. Int. J. Cancer, 58: 763-768, 1994.
80. Borg, A., Baldetorp, B., Ferno, M., Killander, D., Olsson, H., and Sigurdsson, H. ERBB2 amplification in breast cancer with a high rate of proliferation. Oncogene, 6: 137-143, 1991.
81. Knyazev, P. G., Imyanitov, E. N., Chernitca, O. I., Nikiforova, I. F., and Hanson, K. P. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR. Oncology, 49: 162-165, 1992.
82. Kallioniemi, O-P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., and Gray, J. W. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA, 89: 5321-5325, 1992.
83. An, H. X., Niederacher, D., Beckmann, M. W., Gohring, U. J., Scharl, A., Picard, F., van Roeyen, C., Schnurch, H. G., and Bender, H. G. ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues. Int. J. Cancer, 64: 291-297, 1995.
84. An, H. X., Niederacher, D., Dominik, S. I., Kuschel, B., Yan, H., Dall, P., Schnurch, H. G., Bender, H. G., and Beckmann, M. W. int-2 and c-erbE-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction. Anticancer Res., 17: 3133-3136, 1997.
85. Chen, Y., Dong, J., and Li, C. Amplification and overexpression of c-erbB2 in human breast cancer. Chung-Hua Chung Liu Tsa Chih, 17: 16-19, 1995.
86. Wang, Y. P., Chen, S. Q., and Xue, K. X. Amplification of c-erbB-2 oncogene in colon carcinomas. Chung-Hua I Hsueh Tsa Chih, 74: 536-538, 1994.
87. Murphy, D. S., Hoare, S. F., Going, J. J., Mallon, E. E., George, W. D., Kaye, S. B., Brown, R., Black, D. M., and Keith, W. N. Characterization of extensive genetic alterations in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis. J. Natl. Cancer Inst., 87: 1694-1704, 1995.
88. Beckhardt, R. N., Kiyokawa, N., Xi, L., Liu, T. J., Hung, M. C., el-Naggar, A. K., Zhang, H. Z., and Clayman, G. L. HER-2/neu oncogene characterization in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 121: 1265-1270, 1995.
89. Freeman, M. R., Washecka, R., and Chung, L. W. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers. Cancer Res., 49: 6221-6225, 1989.
90. Sato, K., Kato, T., and Moriyama, M. Int-2 and c-erbB-2 gene amplification in urological cancers. Nippon Hinyokika Gakkai Zasshi, 83: 1957-1963, 1992.
91. Stumm, G., Eberwein, S., Rostock-Wolf, S., Stein, H., Pomer, S., Schlegel, J., and Waldherr, R. Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis. Int. J. Cancer, 69: 17-22, 1996.
92. Zhang, X. H., Takenaka, I., Sato, C., and Sakamoto, H. p53 and HER-2 alterations in renal cell carcinoma. Urology, 50: 636-642, 1997.
93. Shiraishi, M., Noguchi, M., Shimosato, Y., and Sekiya, T. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res., 49: 6474-6479, 1989.
94. Bongiorno, P. F., Whyte, R. I., Lesser, E. J., Moore, J. H., Orringer, M. B., and Beer, D. G. Alterations of K-ras, p53, and crbB-2/neu in human lung adenocarcinomas. J. Thorac. Cardiovasc. Surg., 107: 590-595, 1994.
95. Fajac, A., Benard, J., Lhomme, C., Rey, A., Duvillard, P., Rochard, F., Bernaudin, J. F., and Riou, G. c-erbB2 gene amplification and protein expression in ovarian epithelial tumors: evaluation of their respective prognostic significance by multivariate analysis. Int. J. Cancer. 64: 146-151, 1995.
96. Fan, Q. B., Bian, M. L., and Huang, S. Z. The relation between prognosis and amplification of the c-erbB-2 (HER-2/neu) proto-oncogene in ovarian carcinomas. Chung-Hua I Hsueh Tsa Chih, 74: 683-685, 1994.
97. Hou, Y., Wang, M., and Liu, W. Study of the amplification and expression of c-erbB2 oncogene in epithelial ovarian tumors. Chung-Hua Chung Liu Tsa Chih, 18: 426-428, 1996.
98. Kameda, T., Yasui, W., Yoshida, K., Tsujino, T., Nakayama, H., Ito, M., Ito, H., and Tahara, E. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res., 50: 8002-8009, 1990.
99. Tsujino, T., Yoshida, K., Nakayama, H., Ito, H., Shimosato, T., and Tahara, E. Alterations of oncogenes in metastatic tumours of human gastric carcinomas. Br. J. Cancer, 62: 226-230, 1990.